Maypro Group has announced that May Yamada-Lifton is the company’s new chief executive office (CEO). The company’s previous CEO and founder, Steve Yamada, will assume the role of chairman.
Maypro Group (Purchase, NY) has announced that May Yamada-Lifton is the company’s new chief executive office (CEO). The company’s previous CEO and founder, Steve Yamada, will assume the role of chairman and will oversee special projects and support the development of the group’s Asia business, explained Maypro in a press release.
“We are very happy that May will bring her extensive corporate and innovation experience to take Maypro to the next phase of its growth,” said Yamada, in a press release. “Together with May, we will continue to use our entrepreneurial spirit to bring health and happiness to humankind.”
Yamada-Lifton has been working as Maypro’s chief operating office since 2021 after spending 20 years in the pharmaceutical industry, including 13 years at Pfizer. She holds an MBA with honors from Columbia Business School and two Bachelor’s degress; one from the Massachussetts Institute of Technology and one from the University of Tokyo. Yamada-Lifton also serves as a co-chair of the Women in Nutraceuticals’ Mentorship Committee.
“I am very proud of my father’s incredible accomplishments as an Asian immigrant who built a large business from zero” said Yamada-Lifton, in a statement. “I hope to continue his legacy as an Asian-American female CEO.”
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.